Parameter
| Biomarker | CD109 | Full name | CD109 Antigen | Molecular Type | Protein |
|---|---|---|---|---|---|
| Molecular Formula | Molecular Weight | Core Functional Dimensions | Diagnosis | ||
| Disease | Acute Myeloid Leukemia (AML) | Disease Subtypes | / | ||
| Organ | Blood, bone marrow | Test Sample / Technology Platform | Bone marrow/AML cell line (RNA sequencing, in vitro validation). | ||
| Pathobiological Mechanisms | Overexpression in AML cell lines, involved in T-cell receptor pathway dysregulation, and reduced immune response. | ||||
| Clinical Availability Status | Research Verification: Identification of potential biomarkers through transcriptome analysis. | ||||
| Notes and Dynamics | As a candidate molecule for AML diagnosis, it needs further clinical validation when used in conjunction with LRP12. | ||||